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Abstract 
Tramadol is a centrally acting opioid analgesic used to treat moderate 
to sever pain. It has more advantage and less opioid adverse effects 
than conventional opioid analgesia. 
Background: 
This article reports a patient with tramadol dependency that had 
psychosis after tramadol withdrawal. 
Case Report: 
By the increase of tramadol usage for relief of chronic pain, tramadol 
abuse and dependency is increased. Some of tramadol withdrawal 
symptoms are not related to opioid, for example when the 
effectiveness is not only on opioid receptors, but on catecholamine and 
serotonin receptors. So, together with typical symptoms of withdrawal, 
atypical symptomes had been reported. Psychosis is one of tramadol 
atypical withdrawal symptoms which subsided a few days after 
suppression of withdrawal symptoms. In such cases, the diagnosis is 
substance withdrawal instead of psychotic disorder due to substance 
withdrawal and treatment is based on this diagnosis. 
Conclusion 
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Introduction  
Tramadol was first suggested for the treatment of 
post operative and chronic pain in 1970 in 
Germany.1 It was approved in 1994 in UK and 
entered the markets of the United States after the 
Food and Drug Administration (FDA) approved 
it in 1995.2,3 It is used both orally and in injection 
form to treat mild to severe pain.4 An oral dose of 
50-100 mg every 4-6 hours with maximum 100 
mg per day and a single 50-100 mg IM or IV in 2-3 
minutes for treatment of post operative pain is 
suggested.5 
 Tramadol Hydrochloride is a centrally acting 
opioid analgesic that affects µ receptors and 
increases central nervous system (CNS) 
catecholamine and serotonin2,5-7 and as a result 
has serious interactions with mono amine oxidase 
(MAO) reuptake inhibitors, serotonin reuptake 
blockers and tricyclis antidepressants.5 
 Tramadol's side effects include nausea, 
vomiting, drawsiness, dry mouth, perspiration, 
dizziness, tremor, confusion, hallucination, blood 
pressure instability, and exacerbation of 
convulsions. Most side effects develop in the first 
seven days of treatment and the interesting point 
is that only 10% of reported reactions are 
psychological.5 
 Tramadol has less respiratory suppression and 
constipation comparing to opioids5 and there is 
even a belief that it does not have respiratory 
suppression like morphine.8,9 A study in the US 
reported tramadol abuse to be one in a hundred 
thousand people.10 At first, dependency risk of 
tramadol was assumed to be very low,3 but 
following its extensive use for chronic pain relief 
and also in drug abuse cases, dependency was 
observed.11 In Iran, tramadol has been used as an 
analgesic for several years and there is no 
restrictions to its sale and distribution. However, 
concerning the high number of drug addicts, 
tramadol abuse is also increasing. Some drug 
addicts even use it for opium cessation without 
prescription, which increases its dependency 
prevalence. Also in some addicts tramadol 
dependency is added to the opiate dependency. 
On the other hand, tramadol is one of the few 
strong analgesics in Iran's drug market and the 
cultural tendency towards quick and 
symptomatic pain relief increases its usage. As a 
result, we are facing more cases of tramadol 
dependency followed by symptoms of 
withdrawal in clinics. 
 Because tramadol affects catecholamines and 
serotonins as well as µ receptors, some of its 
withdrawal symptoms are not related to opioid.12 
It is therefore necessary to determine tramadol 
withdrawal symptoms. 
Tramadol withdrawal symptoms are in two 
forms of natural (typical) and unnatural 
(atypical). There are rare atypical symptoms 
reported with the tramadol withdrawal so far.  
This case report presents psychotic symptoms 
as a tramadol atypical withdrawal symptom in a 
person referred with no history of any drug or 
opioid dependency. 
 
Case Report  
Patient was an unemployed 30-year-old single 
male with high school diploma from Kerman and 
was admitted in Beheshti Hospital for the first 
time. The reason for his referral was severe 
agitation and anxiety in past week following 
sudden tramadol cessation. He said that the cause 
of his agitation and anxiety was fear of the 
security police force that had been following and 
threatening him and wanted to kidnap him. He 
also believed that some black points were formed 
in his memory and he could see god in television 
and could see some tiny creatures around him. 
He also had some severe withdrawal symptoms 
as rhinorrhea, epiphora, nausea, diarrhea, 
musculoskeletal pains, tremors, tic in his 
shoulders and head, agitation, headache, and 
sleeplessness. 
 He had a history of heroin and opiate 
addiction for several years and during cessation 
started using tramadol. After complete heroin 
and opiate cessation about 2 years ago, he was 
taking 300mg of tramadol per day until a week 
ago when he suddenly stopped taking tramadol 
and was referred to this center with the above 
mentioned symptoms. In his history there was no 
evidence of opioid abuse in past 2 years. He had 
no family history of any specific mental or 
physical illness. 
 In psychological examination, he was well 
alert and had time, place and person orientation. 
His concentration and attention was reduced. He 
was anxious and had normal affection. 
Restlessness was revealed in his psychomotor 
examination. 
 He had persecutory delusion, delusional 
mood, and first stage of trema,13 and had 
Lilliputian hallucinations. 
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 Neurological examination was normal and 
EEG, brain CT scan, and MRI showed no organic 
abnormalities. Based on DSM-IV, tramadol 
withdrawal syndrome was considered at the 
admission and psychosis following drug 
cessation was the differential diagnosis.14 The 
patient was treated with analgesic, sedative, and 
hypnotic drugs but antipsychotic was not 
prescribed. After 3 days all physical and mental 
symptoms including hallucinations and delusions 
completely subsided. Therefore tramadol 
cessation diagnosis was confirmed and psychosis 
following drug withdrawal syndrome was ruled 
out. 
 
Discussion 
Since tramadol binds to opioid µ receptors, it is 
expected that its cessation after chronic use cause 
withdrawal symptoms and signs. However, in 
some cases tramadol withdrawal symptoms are 
similar to serotonin reuptake blockers withdrawal 
symptoms rather than opioid blockers and this 
may be related to tramadol mechanism of action 
as a serotonin and epinephrine reuptake blocker. 
Tramadol withdrawal symptoms and signs 
include typical and atypical types. Symptoms 
normally seen in tramadol withdrawal according 
to their prevalence are as follows: gastrointestinal 
pain, anxiety, bone pain, depression, diarrhea, 
insomnia, epiphora, nausea, agitation, rhinorrhea, 
excessive perspiration. Atypical symptoms 
include severe anxiety, panic attacks, unusual 
CNS symptoms such as confusion, delusion, 
derealization, depersonalization, paranoid 
thoughts (2.27% prevalence), unnatural sensory 
experiences such as numbness, tingling, prickling, 
tinnitus (4.25% prevalence) and hapatic, visual, 
and auditory hallucinations (20% prevalence). It 
should be mentioned that typical symptoms are 
usually seen during the withdrawal period and 
just in one out of eight cases, atypical symptoms 
appear.12 
 According to a case report, administration of a 
therapeutic dose of tramadol to control cancer 
pain caused auditory hallucinations in a 74-year-
old man.12 
Yates et al10 presented a 29-year-old female 
who was first used tramadol to control her pain 
due to carpal tunnel syndrome and became 
dependent to a daily 30-50mg dose for three years 
while she took no other drugs or opioids. During 
tramadol withdrawal, she developed severe 
symptoms including vertigo, diarrhea, headaches 
and insomnia. 
 Recently, high rate of tramadol abuse has been 
noticed12 and even though in most cases, it is 
associated with opioid dependency, there are 
some cases of only tramadol dependency.10 
There are evidences that only a few patients 
with tramadol dependency are susceptible to 
atypical withdrawal symptoms; Senay et al12 
reported no relation between age, sex, drug intake 
duration and history of accompanying drug 
dependency and it was not predictable, but many 
patients who experienced atypical symptoms 
were taking more than 400mg tramadol per day. 
Senay et al,12 in their recommendations, ask 
physicians and other health authorities to pay 
attention to tramadol withdrawal atypical 
symptoms such as hallucinations and delusions 
and do not justify them with drug withdrawal 
psychosis or delirium. In our reported patient, 
tramadol withdrawal psychosis was ruled out 
because the symptoms subsided in a few days 
without any antipsychotic prescriptions and the 
definite diagnosis was atypical symptoms of 
tramadol withdrawal. Regarding the high rate of 
tramadol usage as an analgesic drug, and the fact 
that it is marketed without scheduling under the 
Controlled Substances Act while it causes various 
side effects, drug interactions, dependency risk 
and unusual withdrawal symptoms, physicians 
and health care professionals as well as public 
need to be aware of the unusual symptoms as 
well as quick recovery of its psychotic symptoms 
after controlling withdrawal symptoms. In order 
to avoid unnecessary medications, diagnosis for 
psychotic disorder following tramadol 
withdrawal should be considered just in cases 
that controlling withdrawal symptoms do not 
lead to recovery. 
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  :مقدمه
  چكيده
درد متوسط تا  ترامادول هيدروكلرايد يك ضد درد اپيوئيدي فعال كننده مركزي است كه براي كنترل
  . رود و نسبت به اپيوئيدها مزاياي بهتري و عوارض كمتري دارد شديد به كار مي
دنبال قطع ناگهاني آن دچار ه پردازد كه ب اين مقاله به معرفي بيماري با وابستگي به ترامادول مي  :مورد گزارش
  .شده بود پريشي روان
در تسكين دردهاي مزمن موارد روز افزون از سوء مصرف و  ولترامادرويه  با توجه به استفاده بي  گيري نتيجه
هاي كاتكولامين و سروتونين  دليل تأثير ترامادول بر گيرندهه ب. وابستگي به آن مشاهده شده است
علائم  هاي اپيوئيدي برخي از علائم بازگيري آن مربوط به اپيوئيدها نيست و در كنار علاوه بر گيرنده
از جمله اين علائم، . گزارش شده است ي از علائم بازگيري غير طبيعي نيزطبيعي بازگيري موارد
 ؛يابد نيز بهبود مي پريشي روانباشد كه بعد از چند روز با فروكش علائم بازگيري،  مي پريشي روان
، متعاقب بازگيري مواد پريشي روانجاي تشخيص اختلالات ه رسد در اين موارد ب بنابراين به نظر مي
  .رمان را طبق اين تشخيص انجام دادبيشتر مطرح است و بايد د( ترامادول)تشخيص ترك مواد 
  پريشي، بازگيري غير طبيعي ترامادول، روان  :واژگان كليدي
  :تعداد صفحات
  :ها تعداد جدول
  :تعداد نمودارها
  :تعداد منابع
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